Key result
Multimodality cardiovascular imaging enables early detection and management of cancer therapy-related cardiotoxicity.
Why the study?
Cancer treatments increase survival rates but expose patients to short- and long-term cardiovascular side effects and cardiotoxicity.
This review discusses the applicability of imaging methods for monitoring and diagnosing ventricular dysfunction in cancer patients at risk of cardiotoxicity.
Answers are grounded in this paper and cite their sources.
Highlights potential role of multimodality imaging in cardiotoxicity; leaves open validation in prospective trials before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mesquita et al. (2022) conducted a review in Cancer therapy-related cardiotoxicity. Cardiovascular imaging methods (Echocardiography, MRI, Nuclear Medicine) was evaluated. Judicious use of multimodality cardiovascular imaging techniques, including echocardiography, magnetic resonance imaging, and nuclear medicine, is fundamental for the early detection and management of cancer therapy-related cardiotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: